| Sign In to gain access to subscriptions and/or personal tools. |
An investigation of new toxicity test method performance in validation studies: 2. comparison of three measures of toxicity test performanceThe Gillette Company, Gillette Environment, Health & Safety, Needham, Massachusetts 02914, USA; Gillette Environment, Health & Safety, 37 A Street, Needham, Massachusetts 02914, USA;leon_bruner{at}gillette.com
The Procter & Gamble Company, Miami Valley Laboratories, Cincinnati, Ohio, USA
Institute for In Vitro Sciences, Gaithersburg, Maryland, USA An area that requires further research is how best to measure test method performance in validation studies and how to set criteria that should be used to judge the adequacy of this performance. The studies reported here were designed to begin an investigation of these questions. Computer simulations were used to generate data sets similar to those that might be obtained from a large validation study. These data were then analysed using three procedures including determination of the 95% prediction interval (PI), calculation of Pearson's correlation coefficient and calculation of the contingent probability statistics (CPS), sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). The results of this work suggest that of the three approaches examined, quantitative measurements with calculation of the 95% PI provide the most information to allow discrimination between the performance of several different NTMs. The results also suggest that dividing data sets into positive and negative toxicity classifications followed by the calculation of CPS leads to considerable information loss. This loss of information may be so significant that it is not possible in certain circumstances to distinguish between NTMs that are adequate and those that are not.
Key Words: correlation negative predictive value positive predictive value prediction interval prevalence sensitivity specificity toxicity test performance measurement toxicity test validation validation
Human & Experimental Toxicology, Vol. 21, No. 6,
313-323 (2002) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||